Search Results for "Alnylam"

Alnylam is committed to providing the healthcare community with balanced, accurate, and high-quality information about our science, therapeutic areas, and products.

More than one search term is recommended to yield the most relevant results. By searching, you confirm that your query is unsolicited.

For more information about our FDA-approved therapies, please see the Full Prescribing Information:

Disease Burden and Unmet Need in Hypertension

This slide deck provides a brief overview of uncontrolled hypertension in the US, the associated risks, and the role of tonic blood pressure control.

Carpal Tunnel Release Surgery Handout

This handout provides an overview of two diagnostic algorithms for ATTR amyloidosis in patients with carpal tunnel syndrome.

Safety and Tolerability of Zilebesiran, an RNA Interference Therapeutic Targeting Hepatic Angiotensinogen Synthesis, in Obese Patients with Hypertension

GRAPHICAL ABSTRACT: Zilebesiran as Add-On Therapy in Patients with Hypertension Inadequately Controlled with a Standard Antihypertensive Medication: Efficacy and Safety Results from the KARDIA-2 Study

Development of an X-ray-Based Bone Oxalosis Grading Scale to Access Oxalate Accumulation in Patients with Primary Hyperoxaluria Type 1

Sustained blood pressure reduction with the RNA interference therapeutic, zilebesiran: Primary results from KARDIA 1, a phase 2 study in patients with hypertension

Impact of vutrisiran on outpatient worsening heart failure in patients with transthyretin amyloidosis with cardiomyopathy in the HELIOS-B trial

Hereditary ATTR Amyloidosis: A Closer Look at the V122I Variant External

V122I is the most common variant of hATTR amyloidosis in the United States and is most prevalent in patients of African American descent. Compared to other variants, patients with the V122I variant experience significant disease burden and poorer outcomes.

Zilebesiran as Add-On Therapy in Patients with Hypertension Inadequately Controlled with a Standard Antihypertensive Medication: Efficacy and Safety Results from the KARDIA-2 Study

ATTR Screening and Carrier

ATTR Screening and Carrier

For further information regarding your request, please connect with us by reaching out to your local Medical Science Liaison or contacting our Medical Information team.